FDA Approval Insights: First-Line Luspatercept for Anemia in Lower-Risk MDS
Season 9, Episode 31, Oct 05, 2023, 06:00 PM
Dr Platzbecker discusses the FDA approval of luspatercept in lower-risk MDS with anemia; key efficacy and safety data from the COMMANDS trial; and how this approval addresses historically unmet needs for patients with MDS.